HALO Diagnostics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Human Analytics (HALO) Study (NCT05423860) | HALO Diagnostics | 2022-03-16 |
| A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer (NCT03373006) | HALO Diagnostics | 2018-02-27 |
Track HALO Diagnostics automatically
Every clearance here is in the API, with alerts when new ones post.